Insulin aspart, recombinant Subcutaneous and Peg Intron RP
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Peg Intron RP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: PegIntron, Pegintron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-PEG-3350 with Electolytes
- Insulin aspart, recombinant Subcutaneous-PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride
- Insulin aspart, recombinant Subcutaneous-PEG-Prep and Bisacodyl
- Insulin aspart, recombinant Subcutaneous-PEG3350
- Insulin aspart, recombinant Subcutaneous-Pegademase bovine
- Insulin aspart, recombinant Subcutaneous-Pegademase Bovine Injection
- Peg Intron RP-Insulin degludec
- Peg Intron RP-Insulin Degludec (U-100) Prefilled Pens
- Peg Intron RP-Insulin Degludec (U-100) Vials
- Peg Intron RP-Insulin Degludec (U-200) Prefilled Pens
- Peg Intron RP-Insulin degludec and liraglutide
- Peg Intron RP-Insulin degludec and liraglutide Subcutaneous